Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cytomx Thera (CTMX)

Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,208
  • Shares Outstanding, K 67,732
  • Annual Sales, $ 101,210 K
  • Annual Income, $ -570 K
  • 60-Month Beta 1.00
  • Price/Sales 1.24
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CTMX with:

Options Overview Details

View History
  • Implied Volatility 675.49% ( +515.45%)
  • Historical Volatility 66.81%
  • IV Percentile 99%
  • IV Rank 58.87%
  • IV High 1,127.83% on 09/19/23
  • IV Low 28.02% on 06/21/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 192
  • Volume Avg (30-Day) 125
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 4,170
  • Open Int (30-Day) 3,326

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.02
  • Number of Estimates 4
  • High Estimate 0.02
  • Low Estimate -0.10
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7200 +0.58%
on 04/18/24
2.3100 -25.11%
on 03/21/24
-0.2900 (-14.36%)
since 03/18/24
3-Month
1.3800 +25.36%
on 02/13/24
2.8550 -39.40%
on 03/04/24
+0.0500 (+2.98%)
since 01/18/24
52-Week
1.0400 +66.35%
on 10/30/23
2.8550 -39.40%
on 03/04/24
+0.0800 (+4.85%)
since 04/18/23

Most Recent Stories

More News
CytomX Therapeutics: Q3 Earnings Snapshot

CytomX Therapeutics: Q3 Earnings Snapshot

CTMX : 1.7300 (-1.70%)
CytomX Therapeutics: Q2 Earnings Snapshot

CytomX Therapeutics: Q2 Earnings Snapshot

CTMX : 1.7300 (-1.70%)
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 68.75% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CTMX : 1.7300 (-1.70%)
AGLE : 12.01 (+8.79%)
CytomX Therapeutics: Q1 Earnings Snapshot

CytomX Therapeutics: Q1 Earnings Snapshot

CTMX : 1.7300 (-1.70%)
Codexis (CDXS) Reports Q1 Loss, Lags Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 2.80 (+1.45%)
CTMX : 1.7300 (-1.70%)
Certara, Inc. (CERT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Certara, Inc. (CERT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CERT : 16.21 (-4.37%)
CTMX : 1.7300 (-1.70%)
Will CytomX Therapeutics (CTMX) Report Negative Q1 Earnings? What You Should Know

CytomX Therapeutics (CTMX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CTMX : 1.7300 (-1.70%)
MYGN : 18.51 (-0.70%)
Walgreens, McCormick rise; Invesco Mortgage, CytomX fall

Stocks that traded heavily or had substantial price changes Tuesday: Walgreens, McCormick rise; Invesco Mortgage, CytomX fall

BABA : 68.88 (+0.09%)
IVR : 8.09 (-0.49%)
LYFT : 16.71 (-3.47%)
WBA : 17.59 (-0.23%)
CTMX : 1.7300 (-1.70%)
PVH : 106.31 (+0.53%)
AMZN : 179.22 (-1.14%)
CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -100% and 94.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CTMX : 1.7300 (-1.70%)
SPRO : 1.4700 (-2.00%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new...

BCTX : 2.15 (-0.57%)
ONCY : 1.0300 (-0.96%)
ONC.TO : 1.43 (-0.69%)
CTMX : 1.7300 (-1.70%)
BCT.TO : 2.95 (-0.67%)
RLAY : 6.11 (-1.61%)
HOLX : 75.10 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 1.8392
2nd Resistance Point 1.8133
1st Resistance Point 1.7717
Last Price 1.7300
1st Support Level 1.7042
2nd Support Level 1.6783
3rd Support Level 1.6367

See More

52-Week High 2.8550
Fibonacci 61.8% 2.1617
Fibonacci 50% 1.9475
Fibonacci 38.2% 1.7333
Last Price 1.7300
52-Week Low 1.0400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar